Blood test could cut lung cancer treatment wait time
NCT ID NCT04863924
First seen Jan 04, 2026 · Last updated May 25, 2026 · Updated 22 times
Summary
This study looks at whether a liquid biopsy (a blood test) can help doctors decide on treatment faster for people with advanced non-small cell lung cancer. About 170 adults with newly diagnosed, advanced lung cancer will have their blood tested for genetic changes. The goal is to see if this approach leads to quicker treatment decisions compared to the usual method of testing tumor tissue. The study is not yet recruiting and is led by University Health Network in Toronto.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Princess Margaret Cancer Centre
Toronto, Canada
Conditions
Explore the condition pages connected to this study.